Market closed
Daxor/$DXR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Ticker
$DXR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
45
ISIN
US2394671034
Website
Daxor Metrics
BasicAdvanced
$38M
70.45
$0.11
-0.53
-
Price and volume
Market cap
$38M
Beta
-0.53
52-week high
$8.83
52-week low
$7.10
Average daily volume
5K
Financial strength
Current ratio
0.168
Quick ratio
0.088
Long term debt to equity
2.039
Total debt to equity
2.039
Interest coverage (TTM)
-16.89%
Management effectiveness
Return on assets (TTM)
-2.51%
Return on equity (TTM)
1.54%
Valuation
Price to earnings (TTM)
70.451
Price to revenue (TTM)
315.629
Price to book
1.06
Price to tangible book (TTM)
1.06
Price to free cash flow (TTM)
1,470.957
Growth
Revenue change (TTM)
-26.75%
Earnings per share change (TTM)
86.16%
3-year revenue growth (CAGR)
-24.49%
3-year earnings per share growth (CAGR)
-54.78%
Daxor News
AllArticlesVideos
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
GlobeNewsWire·3 days ago
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
GlobeNewsWire·4 weeks ago
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Daxor stock?
Daxor (DXR) has a market cap of $38M as of May 17, 2025.
What is the P/E ratio for Daxor stock?
The price to earnings (P/E) ratio for Daxor (DXR) stock is 70.45 as of May 17, 2025.
Does Daxor stock pay dividends?
No, Daxor (DXR) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Daxor dividend payment date?
Daxor (DXR) stock does not pay dividends to its shareholders.
What is the beta indicator for Daxor?
Daxor (DXR) has a beta rating of -0.53. This means that it has an inverse relation to market volatility.